Patents by Inventor Karin Bergmann

Karin Bergmann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240173384
    Abstract: The present invention refers to lixisenatide for use in pediatrics.
    Type: Application
    Filed: August 7, 2023
    Publication date: May 30, 2024
    Inventors: Karin Bergmann, Agnes Hincelin-Mery, Christelle Jan
  • Publication number: 20210187075
    Abstract: The present invention refers to lixisenatide for use in pediatrics.
    Type: Application
    Filed: September 22, 2020
    Publication date: June 24, 2021
    Inventors: Karin Bergmann, Agnes Hincelin-Mery, Christelle Jan
  • Publication number: 20190365864
    Abstract: The present invention refers to lixisenatide for use in pediatrics.
    Type: Application
    Filed: February 4, 2019
    Publication date: December 5, 2019
    Inventors: Karin Bergmann, Agnes Hincelin-Mery, Christelle Jan
  • Publication number: 20160235818
    Abstract: The present invention refers to lixisenatide for use in pediatrics.
    Type: Application
    Filed: January 14, 2016
    Publication date: August 18, 2016
    Inventors: Karin Bergmann, Agnes Hincelin-Mery, Christelle Jan
  • Publication number: 20050003436
    Abstract: Intracellular material is released from bacterial, yeast, plant, animal, insect or human cells by the application of a low voltage such as 1 to 10 V to a suspension containing the cells. The conditions may be selected such that DNA released from the cells is electrochemically denatured so as to be available for use in an amplification procedure.
    Type: Application
    Filed: August 3, 2004
    Publication date: January 6, 2005
    Inventors: Sophie Martin, Karin Bergmann, Denise Pollard-Knight
  • Patent number: 6811981
    Abstract: Intracellular material is released from bacterial, yeast, plant, animal, insect or human cells by the application of a low voltage such as 1 to 10 V to a suspension containing the cells. The conditions may be selected such that DNA released from the cells is electrochemically denatured so as to be available for use in an amplification procedure.
    Type: Grant
    Filed: November 28, 2001
    Date of Patent: November 2, 2004
    Assignee: Affymetrix, Inc.
    Inventors: Sophie E. V. Martin, Karin Bergmann, Denise V. Pollard-Knight
  • Publication number: 20020151694
    Abstract: Intracellular material is released from bacterial, yeast, plant, animal, insect or human cells by the application of a low voltage such as 1 to 10 V to a suspension containing the cells. The conditions may be selected such that DNA released from the cells is electrochemically denatured so as to be available for use in an amplification procedure.
    Type: Application
    Filed: November 28, 2001
    Publication date: October 17, 2002
    Applicant: Scientific Generics Limited
    Inventors: Sophie E. V. Martin, Karin Bergmann, Denise V. Pollard-Knight
  • Patent number: 6335161
    Abstract: Intracellular material is released from bacterial, yeast, plant, animal, insect or human cells by the application of a low voltage such as 1 to 10 V to a suspension containing the cells. The conditions may be selected such that DNA released from the cells is electrochemically denatured so as to be available for use in an amplification procedure.
    Type: Grant
    Filed: February 25, 1998
    Date of Patent: January 1, 2002
    Assignee: Scientific Generics Limited
    Inventors: Sophie E.V. Martin, Karin Bergmann, Denise V. Pollard-Knight
  • Patent number: 6333157
    Abstract: dsDNA or other interacting molecules, e.g. antibody and antigen, are disassociated by applying an electrical voltage to a solution containing said molecules in a buffer favoring said disassociation e.g. CHES, CAPS OR CAPSO.
    Type: Grant
    Filed: March 31, 2000
    Date of Patent: December 25, 2001
    Assignee: Affymetrix, Inc.
    Inventors: David N. Miller-Jones, Karin Bergmann, Susan L. Watson
  • Patent number: 5744094
    Abstract: A sterilizing method includes subjecting material, for example packaging board, to laser UV alone, or substantially simultaneously with laser IR and/or hydrogen peroxide to obtain a synergistic effect between the UV and IR and/or hydrogen peroxide, to render micro-organisms present at said material non-viable.
    Type: Grant
    Filed: February 24, 1994
    Date of Patent: April 28, 1998
    Assignee: Elopak Systems AG
    Inventors: Helge Bakketun Castberg, Karin Bergmann, Peter John Hyde, Karen Margaret Montgomery Ness, Christopher John Stanley